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Heterocapsa circularisquama RNA virus (HcRNAV) is the first single-stranded RNA virus to be characterized that infects dino-
flagellates. The ability of HcRNAV coat protein (HcRNAV CP) to self-assemble into virus-like particles (VLPs) in vitro suggested 
that heterologous expression was possible, and that the VLPs might be ideal nanocontainers for the targeted delivery of genes and 
chemicals. In this paper, we report the expression of a codon-optimized HcRNAV 109 CP gene in Pichia pastoris and the produc-
tion of self-assembled HcRNAV VLPs using large-scale fermentation. The HcRNAV 109 CP gene was synthesized according to 
the codon preference of P. pastoris and cloned into a pPICZA vector. The recombinant plasmid pPICZA-CPsyns was transformed 
into P. pastoris by electroporation. The resulting yeast colonies were screened by PCR and analyzed for protein expression by 
SDS polyacrylamide gel electrophoresis. After large-scale fermentation, the yield of HcRNAV CPsyns reached approximately  
2.5 g L1 within 4 d. The HcRNAV VLPs were purified using PEG precipitation followed by cesium chloride density gradient 
ultracentrifugation, and were subsequently analyzed using UV spectrophotometry and transmission electron microscopy. Fluores-
cence dye-labeled myoglobin was loaded into the cages of the HcRNAV VLPs and the encapsulation was confirmed by fluores-
cence spectroscopy. The results point to the possible utilization in pharmacology or nanotechnology of HcRNAV VLPs produced 
by P. pastoris fermentation. 
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Harmful algal blooms (HABs), also known as red tides, 
have had a negative impact on aquatic ecosystems and have 
increasingly become a threat to human and marine health 
[1,2]. Rapid increases in an algal population can lead to 
water discoloration, shading of submerged vegetation, dis-
ruption of food-web dynamics and oxygen depletion in the 
water. HABs are known to have damaged the fishing indus-
try, and to have affected shoreline quality and local econo-
mies. The potent neurotoxins can concentrate in filter- 
feeding shellfish and poison human consumers [3–5]. Even 
non-toxic algae can be harmful when they amass in suffi-
cient numbers. HABs occur in many regions around the 
world, including Scandinavia, the North Pacific, the Carib-
bean and the South Pacific [6,7]. 
The toxic or harmful phytoplanktons that cause HABs 
are commonly dinoflagellates, such as Alexandrium and 
Karenia [8]. Most dinoflagellates have a unique structure 
that includes a nucleus known as the dinokaryon within 
which the chromosomes are attached to the nuclear mem-
brane. Many efforts have been made to control harmful al-
gal blooms with little success [9]. Today, the biological 
control of HABs is considered to be feasible [10]. Viruses 
that are abundant in marine systems replicate rapidly and 
tend to be host-specific, suggesting that single algal species 
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could be targeted [11,12]. Parasites also have the potential 
to control algal bloom species, but their specific role in this 
regard is largely unknown [13]. 
Heterocapsa circularisquama RNA virus (HcRNAV) is 
the first single-stranded RNA virus to be characterized that 
infects dinoflagellates [14]. H. circularisquama Horiguchi, 
first observed in Uranouchi Bay, Japan, is a harmful bloom- 
causing dinoflagellate that specifically kills bivalves [15]. 
HcRNAV particles are polyhedral with a diameter of ap-
proximately 30 nm, and encapsulate a single positive-stranded 
4.4 kb RNA genome. Two open reading frames (ORF-1 and 
ORF-2) were identified in the genome, ORF-2 coding for the 
viral coat protein [16]. HcRNAV targets and accumulates in 
the dinoflagellate nucleus. The virus clones have been di-
vided into types CY and UA (HcRNAV109 and HcRNAV34, 
respectively), based on their host strain specificity [17]. 
The methylotropic yeast, Pichia pastoris, has been shown 
to be a suitable system for the heterologous expression of 
virus coat protein, which could then self assemble into virus- 
like particles (VLPs) in vitro. The successful examples in-
clude cowpea chlorotic mottle virus (CCMV), hepatitis B 
virus (HBV), and bacteriophage Qbeta [18–20]. Besides its 
ability to express foreign proteins at a high level, P. pastoris 
has been shown to have several advantages over other ex-
pression systems. The fermentation period was usually 4–  
5 d, compared to the plant hosts in which production took 
weeks [21]. The synthesized VLPs were soluble and able to 
self-assemble, while production in prokaryote hosts, such as 
E. coli, often results in insoluble inclusions [22]. 
In this paper, we report on the heterologous synthesis of 
HcRNAV 109 coat protein by P. pastoris. The successful 
large-scale fermentation and purification of the self-assem-      
bled HcRNAV VLPs suggest their potential application as 
nanocontainers. To our knowledge, this is the first paper to 
report the heterologous expression of HcRNAV. 
1  Materials and methods 
1.1  Synthesis of P. pastoris codon-optimized HcRNAV 
109 CPsyns 
The sequence of the HcRNAV 109 CP gene, GenBank acces-
sion [AB218609] [23], was redesigned to substitute amino 
acid codons that are seldom used in P. pastoris with those 
more frequently used [24]. Chemical synthesis of the new 
CP gene (CPsyns) was accomplished with GenScript, USA. 
Restriction sites for EcoR I (GAATTC) and Not I (GCGG-    
CCGC) were added upstream and downstream, respectively, 
of the CPsyns gene. The plasmid pUC57-CPsyns was trans-
formed into E. coli Top10 for amplification and preservation.  
1.2  Construction of the recombinant vector pPICZA- 
CPsyns 
The P. pastoris host strain GS115 (his4, histidine-requiring 
auxotroph) and the intracellular expression vector pPICZA 
were purchased from Invitrogen, USA. For the in vivo ex-
pression in P. pastoris, the 1.1-kb CPsyns gene was re-
trieved from the pUC57 vector as an EcoR I/Not I fragment 
and cloned into the corresponding EcoR I and Not I sites of 
the Pichia integrative vector, pPICZA. The resultant vector 
pPICZA-CPsyns was then transformed into E. coli Top10 
for its amplification. 
1.3  Transformation of P. pastoris and cultivation of 
HCRNAV 109 CPsyns  
The transformation and expression of the CPsyns gene in P. 
pastoris was performed using established procedures [25]. 
The recombinant plasmid pPICZA-CPsyns was linearized 
with Sac I and subsequently used to transform P. pastoris 
GS115 by electroporation (Multiporator, Eppendorf, Ger-
many). The transformed yeast cells were incubated in YPD 
agar containing Zeocin at 30°C for 2–3 d. Because the 
CPsyns gene was integrated into the 5′ alcohol oxidase 
promoter (AOX1) locus on the Pichia chromosome, all 
transformants would be His+ Mut+. The CPsyns gene in the 
transformed yeast cells was amplified with PCR using the 
CPsyns and AOX1 primers (data not shown). 
Verified transformants were grown in a buffered glycer-
ol-complex medium (BMGY) at 30°C for 16–20 h. The 
yeast cells were harvested using centrifugation and resus-
pended in buffered methanol-complex medium (BMMY) at 
an optical density of 1.0 at 600 nm (about 5×107 cells mL1). 
Incubation was continued for an additional 96 h at 30°C 
with 1% methanol induction every 24 h. To determine the 
optimal harvest time after induction, 1 mL of the expression 
medium was withdrawn every 12 h and the protein expres-
sion levels were determined using SDS polyacrylamide gel 
electrophoresis (SDS-PAGE). Non-transformed P. pastoris 
GS115 and cells transformed with the expression vector 
pPICZA/GS115 were included as controls for the same in-
duction process. 
1.4  Large scale fermentation of HcRNAV 109 CPsyns 
A positive transformant GS115-24, reliably expressing the 
HcRNAV CPsyns gene, was selected to scale-up CPsyns 
production in a 5-liter fermenter (Fermentec XP 50, Korea) 
using established protocols (Pichia Fermentation Process 
Guidelines, Invitrogen, USA). A total of 10% of the initial 
fermentation volume of GS115-24 in BMGY was inoculated 
into BMGY in the fermenter. One mL of the fermentation 
medium was withdrawn every 12 h to monitor cell growth 
using absorbance at 600 nm. Coat protein expression levels 
were determined using SDS-PAGE. After the glycerol fed- 
batch phase and the methanol fed-batch phase, the culture 
was centrifuged to separate the cells from the supernatant. 
The harvested P. pastoris cells were placed on ice for fur-
ther lysis, while protein concentration was analyzed using 
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the Bradford protein assay. 
1.5  Purification of HcRNAV 109 VLPs 
A modified virus capsid purification procedure based on 
PEG precipitation and density gradient centrifugation was 
employed to purify the soluble assembled HcRNAV VLPs 
[26]. The Pichia cells gathered by centrifugation at 4000×g 
for 30 min were resuspended in five times (w/w) lysis buffer 
(50 mmol L1 sodium phosphate, pH 7.4, 1 mmol L1 PMSF, 
1 mmol L1 EDTA, and 5% glycerol) and disrupted by son-
ication (30 s on, 30 s off, 15 cycles, Vibra-cell VCX-750, 
Sonics, USA). Cell debris and insoluble material were re-
moved by centrifugation at 10000×g for 30 min, and PEG 
6000 was added to the supernatant to a final concentration 
of 10%. After overnight incubation at 4°C, the solution was 
centrifuged at 10000×g for 30 min and the resulting pellet 
was resuspended in phosphate buffer (10 mmol L1 Na2HPO4, 
10 mmol L1 KH2PO4, pH 7.2). The resuspended PEG pellet 
was loaded onto a 10%–40% cesium chloride gradient and 
centrifuged at 35000×g for 2 h. The pellet was dissolved in 
the same phosphate buffer for further analysis. 
1.6  Analysis of purified HcRNAV 109 VLPs 
The purified HcRNAV VLPs were analyzed by UV spec-
trometry and transmission electron microscopy (TEM). Ab-
sorption at 260 nm and 280 nm was measured on a Scinco 
S-3100 UV spectrophotometer (Seoul, Korea), and the A260: 
A280 ratio was calculated. TEM images of VLPs negatively- 
stained with 2%(wt:vol) uranyl acetate were obtained with a 
CM30 electron microscope (FEI/Philips) operated at 200 kV 
(Korea Basic Science Institute, Chunchon Center, Korea) [26]. 
1.7  Encapsulation of fluorescence dye-labeled myoglobin 
Purified HcRNAV VLPs in PBS, obtained from Section 2.5, 
were dialyzed against three changes of disassembly buffer 
(0.05 mol L1 phosphate buffer, 0.15 mol L1 NaCl, 2  
mmol L1 DTT, pH 8.0). Myoglobin was labeled with a 
fluorescent dye, Alexa Fluor 594, according to the Alexa 
Fluor® 594 Protein Labeling Kit (A10239, Invitrogen, USA). 
The disassembled HcRNAV VLPs and fluorescent myoglo-
bin were mixed at the ratio of 5:1 and the resulting mixture 
was incubated at room temperature for 1.5 h. The incubated 
solution was then dialyzed against three changes of reas-
sembly buffer (0.05 mol L1 phosphate buffer, 0.5 mol L1 
NaCl, pH 7.2) and concentrated by freeze-drying. Free my-
oglobin was removed using Vivaspin 6 ultrafiltration spin 
column (Sartorius, Germany). The VLPs containing encap-
sulated myoglobin were further analyzed and purified by 
size exclusion fast performance liquid chromatography (FPLC) 
on Biologic DuoFlowTM Chromatography System (Bio-Rad, 
USA) equipped with a Superose 6 PC 3.2/30 column (flow 
rate 40 L min1, GE Healthcare, USA). The purified myo-
globin-containing HcRNAV capsids were used to perform 
fluorescence spectroscopy (Confocal Laser Scanning Bio-
logical Microscope FV1000, Olympus, Japan) [27]. 
2  Results and discussion 
2.1  Construction of expression vector pPICZA-CPsyns 
The P. pastoris expression system was chosen due to its 
relatively simple fermentation protocol and high final cell 
density. To enhance the efficiency of gene expression, the 
HcRNAV CPsyns gene was optimized to the codon usage 
of P. pastoris (Figure 1). The synthesized 1080 bp sequence 
showed 95.6% nucleotide identity (1033/1080) and 100% 
deduced amino acid identity with the native HcRNAV 109 
CP gene. The inclusion of seldom-used codons in P. pas-
toris, such as CGG (arginine) and GCG (alanine), can lead 
to low efficiency of gene translation via early termination. 
These codon alterations (CGG→AGA, GCG→GGT) were 
expected significantly to improve the expression level of 
foreign proteins. In total, 47 changes were introduced into 
the synthesized gene. The resulting HcRNAV CPsyns was 
then inserted into the pPICZA plasmid. The digestion of the 
recombinant vector by EcoR I and Not I showed two bands 
of 3.3 kb (pPICZA) and 1.1 kb (CPsyns), which indicated 
that the expression vector pPICZA-CPsyns was constructed 
successfully (Figure 2). 
2.2  Expression of the HcRNAV 109 CPsyns gene in P. 
pastoris 
After screening on Zeocin-YPD plates, over 10 P. pastoris 
transformants were induced with methanol and examined 
for HcRNAV CPsyns production. Each supernatant (5 L) 
after cell lysis was subjected to SDS-PAGE (Figure 3). All 
of the transformants showed a band at approximately 40 kD, 
which was the theoretical molecular weight of the HcRNAV 
coat protein monomer. Transformant GS115-24 was selected 
for further fermentation. 
The P. pastoris transformant GS115-24 grew exponen-
tially for more than 40 h in the glycerol fed-batch phase in 
the 5-liter fermenter. Then, a methanol-fed induction was 
commenced over 72 h with the methanol concentration be-
ginning at 3.6 mL h1 L1 and reaching 10.9 mL h1 L1. The 
maximum wet cell weight reached was 400 g L1 (A600 of 
approximately 160). The concentration of crude HcRNAV 
coat protein approached 2.5 g L1 as determined by the 
Bradford protein assay, which was more than 12-fold the 
yield of HcRNAV CP in the shaking flasks. This is one of 
the highest productions of viral coat protein reported to date. 
2.3  Purification of HcRNAV 109 VLPs 
Recombinant GS115-24 cells were lysed by ultrasonic  
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Figure 1  Nucleotide sequences and deduced amino acid sequence of HcRNAV 109 CP gene (top line) and HcRNAV CPsyns gene (bottom line). The alter-
ations in nucleotide sequence are boxed in gray. 
 
Figure 2  Digestion of pPICZA-CPsyns with EcoR I and Not I. Lane 1, 
digestion of pPICZA-CPsyns with EcoR I; 2, double-digestion of pPICZA- 
CPsyns with EcoR I and Not I; M, Takara 1 kb DNA ladder. 
disruption and the HcRNAV CP purified by PEG precipita-
tion and density gradient centrifugation. PEG treatment of 
the supernatant preferentially precipitated HcRNAV CP  
 
Figure 3  SDS-PAGE of P. pastoris transformants. Lanes 1–3, soluble 
fractions of pPICZA-CPsyns transformants after sonication; 4, control of 
pPICZA/GS115; 5, control of GS115; M, DokDo-MARKTM broad-range.  
with almost no precipitation of other proteins. Ultracentrif-
ugation in CsCl further purified HcRNAV CP to a single 
band of 40 kD, which showed that the coat protein was able 
to assemble into high molecular weight structures (HcR-
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NAV VLPs) (Figure 4). 
2.4  Characterization of purified HcRNAV 109 VLPs 
The VLPs were analyzed by UV spectrophotometry and 
showed an A260:A280 ratio of 1.51, which was similar to the 
ratio of 1.56 observed with other VLPs. 
TEM examination of the VLPs showed spherical parti-
cles of ca. 30 nm diameter (Figure 5). This similarity to 
native HcRNAV particles indicated that the synthesized 
coat protein was successfully expressed and self-assembled 
into VLPs in vitro [14]. 
2.5  Encapsulation of fluorescence dye-labeled myoglobin 
The co-elution of HcRNAV VLPs and guest myoglobin (t = 
36 min) was observed in the FPLC traces (Figure 6), showing 
the same elution time as the original capsids. These pointed 
to the successful reassembly of the viral cage after the  
 
Figure 4  Purification of HcRNAV coat protein. Lane 1, soluble fractions 
of GS115-24 after sonication; 2, HcRNAV CP purified by ultracentrifuga-
tion in CsCl; M, DokDo-MARKTM broad-range.  
 
Figure 5  TEM image of HcRNAV VLPs. The diameter of the capsids 
was about 30 nm. Size bar represents 100 nm. 
 
Figure 6  Size-exclusion FPLC of myoglobin-containing HcRNAV VLPs 
at 280 nm. The peak at elution time of 36 min corresponded to the intact 
virus capsids. 
encapsulation process. 
The correct reassembly of HcRNAV capsids with fluo-
rescent myoglobin was further proven by fluorescence spec-
troscopy. The capsids containing this guest protein dis-
played significant emission at  = 590 nm (Figure 7), indi-
cating that inclusion of myoglobin had occurred successful-
ly. When HcRNAV VLPs were used as control, no emission 
under the same condition was observed. 
3  Conclusion 
HcRNAV 109 coat protein was expressed in Pichia pastoris  
 
Figure 7  Fluorescence spectroscopy of myoglobin-containing HcRNAV 
VLPs. A typical confocal fluorescence image (1.68 m×1.68 m) showed 
the formation of a fluorescent protein encapsulated inside a capsid. Inset: 
AFM image (to scale) at the same sample location, showing that only a 
small fraction of the capsids contained myoglobin molecules. 
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and successfully self-assembled into polyhedral virus-like 
particles. To our knowledge, this is the first report on the 
efficient expression and assembly in P. pastoris of the cap-
sid of a virus infecting a harmful alga. Optimization of co-
dons to those preferred by P. pastoris was necessary for the 
high expression of the foreign gene in the P. pastoris system 
[28]. The successful expression and purification of HcR-
NAV VLPs makes their abundant and rapid production now 
possible. This method also represents a promising tool for 
the preparation of large amounts of VLPs for use in gene 
therapy, vaccine development, and other applications such 
as the control of harmful algal blooms. 
The encapsulation of myoglobin as a model protein in-
side HcRNAV VLPs revealed that these virus capsids de-
rived from P. pastoris were suitable nanocontainers for drug 
delivery and imaging reagent carriers. The specific targeting 
by HcRNAV of H. circularisquama would be extremely 
useful in controlling harmful algal blooms. The encapsula-
tion of algicidal compounds inside the capsids to improve 
the efficiency is another useful approach for future investi-
gation. HcRNAV could become a model virus capsid that 
might be used as a nanoplatform in materials science and 
medicine. Further analysis to compare the properties of the 
recombinant HcRNAV capsids with those of the native 
types is ongoing. The modification of HcRNAV CP by al-
tering certain functional amino acids could also be useful in 
revealing the detailed structure, currently unknown, of the 
HcRNAV capsid.  
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